T1	Participants 492 585	patients with stage III colon cancer who enrolled in a phase III clinical trial (NCCTG N0147)
T2	Participants 1394 1423	Caucasians versus other races
T3	Participants 657 747	DNA extracted from whole blood (n = 2,834) and compared with paired tumor tissue (n = 977)
